Shaomeng Wang
Co-Founder, Chief Scientific Advisor & Non-Executive DirectorDr. Shaomeng Wang, Ph.D, Co-founded Ascentage Pharma Group International and its Director since November 17, 2017 and also served its Chairman of Scientific Advisory Board from 2010 until 2023 and is its Chief Scientific Advisor since 2023. Dr. Wang co-founded Ascentage Pharma Group Corporation, Ltd. in 2009 and serves as its Member of Advisory Board and Director. Dr. Wang Co-Founded OncoFusion Therapeutics Inc. in 2012 and serves as its Chief Scientific Officer. He serves as President at Oncopia Therapeutics, LLC. Dr. Wang was the Co-Founder and Director at Ascenta Therapeutics, Inc. He served as an Assistant Professor in Georgetown University from 1996-2000 and an Associate Professor from 2000 to 2001. He joined the faculty at the University of Michigan Medical School as a tenured Associate Professor in 2001. Dr. Wang has authored and co-authored 80+ publications in peer-reviewed scientific journals and 50+ meeting abstracts and is an inventor on more than 10 international and US patents. Dr. Wang has served as a consultant for pharmaceutical companies. He was Co-Director of the Experimental Therapeutics Program at the University of Michigan Comprehensive Cancer Center, as well as Director of Therapeutics Discovery at the Michigan Center for Translational Pathology. Dr. Wang serves as Director of the Cancer Drug Discovery Program. He serves as a Director at Oncopia Therapeutics, LLC. Dr. Wang has been a Director of Ascentage since 2009. Dr. Wang has over 230 publications and is an inventor on 40 patents (view publications). Dr. Wang is also the editor-in-chief of the Journal of Medicinal Chemistry, the most cited journal in the field of medicinal chemistry. Dr. Wang is an innovative leader in structure-based design of target-specific medicines and in computational chemistry and biology and informatics. Dr. Wang obtained his Bachelor’s degree in Chemistry from Peking University in July 1986. He received his Ph.D. degree from Case Western Reserve University in Chemistry in the United States in January 1993.
Positions
- Company NameAscentage Pharma Group InternationalStock Code06855PositionCo-Founder, Chief Scientific Advisor & Non-Executive DirectorRelated Securities
